XML Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History

XML Financial’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-7,003	Closed	-$322K	–	235
2022 Q1	$322K	Sell	7,003 -191	-3%	-$9.11K	0.04%	253
2021 Q4	$441K	Buy	7,194 +105	+1%	+$7.26K	0.05%	217
2021 Q3	$530K	Hold	7,089	–	–	0.07%	191
2021 Q2	$656K	Hold	7,089	–	–	0.14%	119
2021 Q1	$629K	Buy	7,089 +920	+15%	+$91.3K	0.15%	113
2020 Q4	$575K	Hold	6,169	–	–	0.15%	115
2020 Q3	$393K	Hold	6,169	–	–	0.12%	130
2020 Q2	$322K	Buy	+6,169	New	+$265K	0.11%	140

Other funds holding ARKG

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

XML Financial's ARKG Position: Q2 2022 in Review

XML Financial sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 7,003 shares — an estimated $322K sold.

XML Financial first reported a position in ARKG in Q2 2020 and held it in 8 quarters. The position peaked at $656K in Q2 2021. 334 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

XML Financial reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
XML Financial sold 7,003 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $322K.
XML Financial first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 8 quarters.
XML Financial's ARK Genomic Revolution ETF position peaked at $656K in Q2 2021.
334 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on XML Financial's 13F filing for Q2 2022, filed 1 Aug 2022.